<DOC>
	<DOCNO>NCT02957877</DOCNO>
	<brief_summary>There lack data literature use low-molecular weight heparin ( LMWH ) anticoagulation nocturnal home hemodialysis ( NHHD ) . This study aim evaluate efficacy safety LMWH , administer infusion method , compare unfractionated heparin anticoagulation NHHD treatment .</brief_summary>
	<brief_title>LMWH Infusion Anticoagulation Home HD</brief_title>
	<detailed_description>Low-molecular weight heparin ( LMWH ) unfractionated heparin ( UFH ) establish systemic anticoagulant patient receive conventional thrice-weekly hemodialysis absence significant bleeding risk . For patient undergo nocturnal home hemodialysis ( NHHD ) , LMWH seldom utilize need additional bolus injection long dialysis treatment , impractical patient sleep hemodialysis . Moreover , potential risk LMWH accumulation due long half-life . As paucity data literature use LMWH NHHD treatment , trial conduct assess safety efficacy LMWH , administer infusion method , particular group dialysis patient .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Nadroparin</mesh_term>
	<criteria>Prevalent NHHD patient receive &gt; 1 year dialysis unfractionated heparin anticoagulant Age &gt; = 18 Informed consent available History intolerance LMWHs HD Receiving warfarin oral anticoagulant Pregnant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Anticoagulation</keyword>
	<keyword>Anti-Xa activity</keyword>
	<keyword>Low-molecular weight heparin</keyword>
	<keyword>Unfractionated heparin</keyword>
</DOC>